We are live on ! Find out more
GCM

GKV Capital Management Portfolio holdings

AUM $310M
1-Year Est. Return 51.56%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+51.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$201M
AUM Growth
-$43.9M
Cap. Flow
-$32M
Cap. Flow %
-15.91%
Top 10 Hldgs %
48.36%
Holding
182
New
22
Increased
21
Reduced
59
Closed
17

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.38M
2
VZ icon
Verizon
VZ
+$1.36M
3
UNH icon
UnitedHealth
UNH
+$1.35M
4
GLD icon
SPDR Gold Trust
GLD
+$608K
5
SPG icon
Simon Property Group
SPG
+$582K

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Healthcare 14.13%
3 Consumer Discretionary 13.2%
4 Industrials 10.65%
5 Financials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
176
Regeneron Pharmaceuticals
REGN
$80.8B
-3,835
Closed -$2.73M
RENT
177
Rent the Runway
RENT
$124M
-3,904
Closed -$33.2K
ROK icon
178
Rockwell Automation
ROK
$49B
-200
Closed -$57.2K
SNPS icon
179
Synopsys
SNPS
$79.7B
-2,015
Closed -$978K
SWKS icon
180
Skyworks Solutions
SWKS
$10.6B
-43
Closed -$3.81K
VST icon
181
Vistra
VST
$47.4B
-6,200
Closed -$855K
ZTS icon
182
Zoetis
ZTS
$30B
-400
Closed -$65.2K

Similar funds

GKV Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, GKV Capital Management held 182 positions worth $201M, down 18% from $245M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

GKV Capital Management withdrew a net $32M in Q1 2025, closing 17 positions and reducing 59 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GKV Capital Management opened a new position in Alibaba worth $529K.

  • GKV Capital Management's largest Q1 2025 buy was Alibaba: 4,000 shares worth $529K.
  • GKV Capital Management added most to Citigroup in Q1 2025, an estimated $1.38M increase.
  • GKV Capital Management's biggest Q1 2025 reduction was Advanced Micro Devices, cutting an estimated $3.98M.
  • GKV Capital Management fully exited Regeneron Pharmaceuticals in Q1 2025, selling an estimated $2.73M.
  • GKV Capital Management's ten largest holdings make up 48% of its $201M portfolio in Q1 2025.
  • GKV Capital Management opened 22 new positions and closed 17 in Q1 2025.
  • GKV Capital Management's portfolio value fell 18% quarter-over-quarter to $201M.

Based on GKV Capital Management's 13F filing for Q1 2025, filed 13 May 2025.